🦠Cell Biology Unit 18 – Extracellular Matrix and Cell Adhesion
The extracellular matrix (ECM) is a complex network of molecules surrounding cells, providing structural support and regulating cellular behavior. Key components include fibrous proteins like collagen and elastin, glycoproteins such as fibronectin and laminin, and proteoglycans.
Cell adhesion molecules (CAMs) mediate interactions between cells and the ECM. Integrins, cadherins, selectins, and immunoglobulin superfamily CAMs play crucial roles in tissue organization, cell signaling, and maintaining tissue integrity. Understanding ECM-cell interactions is vital for grasping tissue function and developing therapeutic strategies.
ECM-bound growth factors (FGF, TGF-β) can be released and activate their respective signaling pathways
Mechanical properties of the ECM (stiffness, elasticity) can influence cell behavior through mechanotransduction
Cells sense and respond to ECM rigidity through integrin-mediated adhesions and actomyosin contractility
ECM-cell interactions are bidirectional, with cells constantly remodeling the ECM in response to various stimuli
ECM in Tissue Organization and Function
ECM provides a structural framework for tissue organization and influences cell behavior and fate
Basement membranes are specialized ECM structures that separate epithelial and endothelial cells from underlying connective tissue
Consist primarily of collagen IV, laminin, and proteoglycans
Regulate cell polarity, differentiation, and tissue compartmentalization
Interstitial matrix is the ECM surrounding cells within connective tissues
Composition varies depending on the tissue type (bone, cartilage, tendon)
Provides mechanical support, facilitates nutrient diffusion, and regulates cell function
ECM guides tissue morphogenesis during development through its influence on cell migration, adhesion, and differentiation
Epithelial-mesenchymal interactions during organogenesis are mediated by ECM components
ECM contributes to tissue-specific functions
Collagen fibers in tendons and ligaments provide tensile strength and resistance to stretching
Proteoglycan-rich matrix in cartilage enables load-bearing and shock absorption
ECM-cell interactions are crucial for maintaining tissue homeostasis and preventing pathological conditions
ECM Remodeling and Dynamics
ECM undergoes constant remodeling in response to physiological and pathological stimuli
Matrix metalloproteinases (MMPs) are a family of enzymes that degrade ECM components
Secreted as inactive proenzymes and activated by proteolytic cleavage
Tightly regulated by tissue inhibitors of metalloproteinases (TIMPs)
Dysregulation of MMP activity can lead to excessive ECM degradation or accumulation, contributing to various diseases
ECM synthesis is mediated by cells such as fibroblasts, chondrocytes, and osteoblasts
Collagen synthesis involves intracellular processing and extracellular fibril assembly
Proteoglycan synthesis occurs in the Golgi apparatus, followed by secretion into the extracellular space
ECM turnover is a balance between synthesis and degradation, maintaining tissue integrity and function
ECM remodeling is essential for wound healing, tissue repair, and regeneration
Provisional matrix (fibrin clot) forms initially, followed by the deposition of collagen and other ECM components
Remodeling of the ECM facilitates cell migration, proliferation, and differentiation during the healing process
Growth factors (TGF-β, PDGF) and mechanical forces can stimulate ECM synthesis and remodeling
Pathological Alterations of ECM and Cell Adhesion
Alterations in ECM composition, structure, or cell adhesion can contribute to various pathological conditions
Fibrosis is characterized by excessive deposition of ECM, particularly collagen, leading to tissue stiffening and dysfunction
Occurs in response to chronic inflammation, injury, or metabolic disorders
Examples include liver cirrhosis, pulmonary fibrosis, and cardiac fibrosis
Basement membrane thickening and ECM accumulation are hallmarks of diabetic complications (nephropathy, retinopathy)
Defects in collagen synthesis or structure can cause connective tissue disorders
Ehlers-Danlos syndrome is characterized by hyperextensible skin and joint hypermobility due to collagen abnormalities
Osteogenesis imperfecta is caused by mutations in collagen I, leading to brittle bones and frequent fractures
Impaired cell adhesion can contribute to tumor metastasis and invasion
Loss of E-cadherin expression in epithelial tumors enables cell detachment and migration
Overexpression of matrix metalloproteinases facilitates ECM degradation and tumor cell invasion
Chronic inflammation can lead to ECM degradation and tissue damage
Rheumatoid arthritis is characterized by synovial inflammation and cartilage destruction mediated by MMPs
Targeting ECM and cell adhesion molecules is a potential therapeutic strategy for various diseases
Practical Applications and Current Research
Tissue engineering and regenerative medicine rely on the manipulation of ECM and cell adhesion to create functional tissue constructs
Biomaterials that mimic the native ECM composition and structure are used as scaffolds for cell growth and differentiation
Decellularized ECM from donor tissues can be used as a natural scaffold for tissue regeneration
ECM-based therapies are being explored for wound healing and tissue repair
Collagen-based dressings and matrices promote wound closure and dermal regeneration
Hyaluronic acid-based hydrogels are used for cartilage repair and joint lubrication
Targeting ECM remodeling enzymes (MMPs, TIMPs) is a potential strategy for treating fibrosis and cancer
MMP inhibitors have been investigated for their anti-tumor and anti-metastatic effects
TIMP delivery has shown promise in reducing fibrosis and promoting tissue regeneration
Cell adhesion molecules are being targeted for drug delivery and immunotherapy
Antibodies against integrins or selectins can be used to deliver drugs specifically to tumor cells or sites of inflammation
CAR T-cell therapy involves genetically modifying T cells to express chimeric antigen receptors that target tumor-specific adhesion molecules
High-throughput screening and proteomics approaches are being used to identify novel ECM and cell adhesion targets for therapeutic intervention
Advances in imaging techniques (super-resolution microscopy, atomic force microscopy) are providing new insights into the nanoscale organization and dynamics of ECM and cell adhesion complexes